Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-04 Sale | 2026-03-06 4:05 pm | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 2,437 | $475.3 | $1,158,306 | 15,122 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 4:21 pm | VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy EVP and Chief Legal Officer | 892 | $495.96 | $442,396 | 22,811 (Direct) | View |
| 2026-02-27 Sale | 2026-03-03 4:34 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 40,000 | $493.47 | $19,738,855 | 98,278 (Direct) | View |
| 2026-02-27 Sale | 2026-03-03 4:25 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 2,329 | $480.31 | $1,118,642 | 37,734 (Direct) | View |
| 2026-02-26 Sale | 2026-03-02 4:10 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 357 | $483.36 | $172,560 | 6,624 (Direct) | View |
| 2026-02-25 Sale | 2026-02-26 6:55 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 260 | $486.35 | $126,451 | 46,763 (Direct) | View |
| 2026-02-25 Sale | 2026-02-26 6:50 pm | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 1,846 | $486.35 | $897,802 | 65,753 (Indirect Direct) | View |
| 2026-02-25 Sale | 2026-02-26 6:48 pm | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 4,910 | $487.65 | $2,394,365 | 17,559 (Direct) | View |
| 2026-02-25 Sale | 2026-02-26 6:06 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 620 | $486.35 | $301,537 | 7,284 (Direct) | View |
| 2026-02-25 Sale | 2026-02-26 6:01 pm | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 945 | $486.35 | $459,601 | 13,659 (Direct) | View |
| 2026-02-25 Sale | 2026-02-26 6:00 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 668 | $486.35 | $324,882 | 18,432 (Direct) | View |
| 2026-02-25 Sale | 2026-02-26 5:56 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 223 | $486.35 | $108,456 | 6,981 (Direct) | View |
| 2026-02-19 Sale | 2026-02-23 4:21 pm | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 58,613 | $468.83 | $27,479,583 | 69,117 (Indirect Direct) | View |
| 2026-02-17 Sale | 2026-02-19 4:28 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 977 | $483.52 | $472,395 | 48,650 (Direct) | View |
| 2026-02-17 Sale | 2026-02-19 4:12 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 3,619 | $484.31 | $1,752,704 | 8,486 (Direct) | View |
| 2026-02-17 Sale | 2026-02-19 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 3,720 | $484.18 | $1,801,161 | 15,748 (Direct) | View |
| 2026-02-17 Sale | 2026-02-19 4:06 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 2,848 | $484.93 | $1,381,090 | 20,727 (Direct) | View |
| 2026-02-17 Sale | 2026-02-19 4:03 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 2,195 | $484.87 | $1,064,297 | 7,750 (Direct) | View |
| 2026-02-13 Sale | 2026-02-18 4:43 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 1,500 | $499.99 | $749,985 | 46,132 (Direct) | View |
| 2026-02-13 Sale | 2026-02-18 4:26 pm | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 988 | $499 | $493,012 | 16,838 (Direct) | View |
| 2026-02-13 Sale | 2026-02-18 4:23 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director | 266 | $500 | $133,000 | 4,299 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-03-03 4:41 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy EVP and Chief Legal Officer | 0 | $0 | 36,110 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-26 6:56 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP, CO & FO | 1,744 | $485.11 | 47,042 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-26 6:55 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 1,627 | $485.11 | 46,763 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-26 6:50 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 1,518 | $485.11 | 65,753 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-26 6:48 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 873 | $485.11 | 17,559 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-26 6:11 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman | 3,547 | $485.11 | 35,237 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-26 6:09 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 4,981 | $485.11 | 138,278 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-26 6:06 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 582 | $485.11 | 7,284 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-26 6:05 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 1,453 | $485.11 | 40,063 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-26 6:01 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 1,144 | $485.11 | 13,659 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-26 6:00 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,627 | $485.11 | 18,432 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-26 5:56 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 546 | $485.11 | 6,981 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-23 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 25,026 | $187.53 | 69,117 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-23 4:21 pm | N/A 2028-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 48,505 | $0 | 69,117 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-23 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 23,479 | $155.57 | 69,117 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 4:30 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP, CO & FO | 2,294 | $483.75 | 48,786 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:30 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP, CO & FO | 7,365 | $0 | 48,786 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 4:28 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 2,294 | $483.75 | 48,650 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:28 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 5,789 | $0 | 48,650 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 4:24 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 2,140 | $483.75 | 79,225 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:24 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 5,789 | $0 | 79,225 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 1,148 | $483.75 | 23,342 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 4,962 | $0 | 23,342 (Direct) | View |
| 2026-02-18 Tax Withholding | 2026-02-19 4:18 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman | 2,964 | $483.75 | 38,784 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:18 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman | 8,269 | $0 | 38,784 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 4:16 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 6,554 | $483.75 | 143,259 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:16 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 16,326 | $0 | 143,259 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 1,110 | $483.75 | 8,486 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 2,584 | $0 | 8,486 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 4:10 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 1,912 | $483.75 | 41,516 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:10 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 5,375 | $0 | 41,516 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 4:08 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 1,505 | $483.75 | 15,748 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:08 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 4,135 | $0 | 15,748 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 4:06 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,530 | $483.75 | 20,727 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:06 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 4,962 | $0 | 20,727 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 4:03 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 598 | $483.75 | 7,750 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:03 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 1,809 | $0 | 7,750 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 4:47 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP, CO & FO | 4,565 | $487.76 | 43,715 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 4:43 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 3,804 | $487.76 | 46,132 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 4:39 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 3,548 | $487.76 | 75,576 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 4:37 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 2,283 | $487.76 | 19,528 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 4:35 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 13,041 | $487.76 | 133,487 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 4:32 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 2,283 | $487.76 | 10,631 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 4:28 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 3,804 | $487.76 | 38,053 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 4:26 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 2,993 | $487.76 | 16,838 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 4:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,903 | $487.76 | 20,143 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 4:17 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 1,393 | $487.76 | 8,734 (Direct) | View |